A Phase 3 Study of JNS020QD in Patients With Chronic Pain.

Trial Profile

A Phase 3 Study of JNS020QD in Patients With Chronic Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Dec 2012 Actual initiation date changed from Aug 2011 to Oct 2011 as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Planned end date changed from 1 Jan 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top